International E-publication: Publish Projects, Dissertation, Theses, Books, Souvenir, Conference Proceeding with ISBN.  International E-Bulletin: Information/News regarding: Academics and Research

A new improved Stability-Indicating RP-HPLC method for Determination of Diosmin and hesperidin in combination

    , , , ,

Author Affiliations

  • 1Department of Pharmaceutics, College of Pharmacy, Salman Bin Abdulaziz University, Al-kharj, Kingdom of Saudi Arabia
  • 2Department of Pharmacogonosy, College of Pharmacy, Salman Bin Abdulaziz University, Al-kharj, Kingdom of Saudi Arabia
  • 3Department of Pharmacogonosy, College of Pharmacy, Alexandria University, Alexandria, EGYPT

Int. Res. J. Biological Sci., Volume 3, Issue (6), Pages 41-46, June,10 (2014)

Abstract

A rapid, simple, precise and cost effective stability-indicating RP-HPLC method has been developed and validated for determination of diosmin and hesperidin in combination. The mobile phase consisted of mixture of methanol: water (45:55 v/v). UV detection was performed at 346 nm. The method was linear over the concentration ranges 4.8-7.2 g mL-1, and 20-40 g mL-1 with correlation coefficient 0.999 both for diosmin and hesperidin. The developed method was validated as per ICH guidelines. The recovery of diosmin and hesperidin were in the range of 100.3 to 102.2 %. The limit of detection and limit of quantitation were 0.0102 and 0.0311g mL-1for diosmin and 0.0558 and 0.1693 g mL-1for hesperidin respectively. The proposed method is reproducible, accurate, robust and suitable for the simultaneous quantitative analysis of the studied drugs in bulk and dosage formulation.

References

  1. Mishra G. Srivastava V.K. and Tripathi A., Analytical method development and validation for assay of Diosmin and Hesperidin in combined tablet dosage form by RP- HPLC, Int. J. Pharm. Life. Sci., 4, 2834-2839 (2013)
  2. Cova D. De Angelis L. and Giavarini F., Pharmacokinetics and metabolism of oral diosmin in healthy volunteers, Int. J.Clin.Pharmacol.Ther.Toxicol., 30, 29-33 (1992)
  3. Lyseng-Williamson K.A. and Perry C.
  4. M.,Micronised purified flavonoid fraction: a review of its use in chronic Venous Insufficiency,Venous Ulcers and Haemorrhoids.,63, 71-100(2003)
  5. Dakora F.D., Plant flavonoids: biological molecules for useful exploitation, J.Plant.Physiol.,22, 87–99 (1995)
  6. Das A. Wang J.H.and Lien E.J., Carcinogenicity, mutagenicity and cancer preventing activities of flavonoids: a structure–system–activity relationship (SSAR) analysis,Prog. Drug. Res.,42, 133–166(1994)
  7. Sato M.Ramarathnam N. Suzuki Y. Ohkubo T. Takeuchi M. and Ochi H., Varietal differences in the phenolic content and superoxide radical scavenging potential of wines from different sources, J. Agric. Food. Chem.,44,37–41(1996)
  8. Cook NC and Samman S. Flavonoids-chemistry, metabolism, cardioprotective effects, and dietary sources, J NutrBiochem., 7, 66–76 (1996)
  9. Ficarra R.Ficarra P.Tommasini S.Calabro M.L. Ragusa S.Barbera R. and Rapisarda A., Leaf extracts of some Cordia species: analgesic and anti-inflammatory activities as well as their chromatographic analysis, Farmaco., 50,245–256 (1995)
  10. Garg A., Garg S., Zaneveld L.J. and Singla A.K., Chemistry and pharmacology of the Citrus bioflavonoid hesperidin, Phytothe.r Res., 15, 655-69 (2001)
  11. Chiba H. Uehara M. Wu J. Wang X. Masuyama R. Suzuki K. Kanazawa K. and Ishimi Y., Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice, J.Nutr.,133, 1892-1897 (2003)
  12. Saeidi I.Hadjmohammadi M.R.Peyrovi M.Iranshahi M.Barfi B.Babaei A.B. and Dust., A.M. HPLC determination of hesperidin, diosmin and eriocitrin in Iranian lime juice using polyamide as an adsorbent for solid phase extraction, J. Pharm. Biomed. Anal., 56, 419-422 (2011)
  13. El-Shafae A.M. and El-Domiaty M.M.,Improved LC methods for the determination of diosmin and/or hesperidin in plant extracts and pharmaceutical formulations, J. Pharm. Biomed. Anal., 26, 539-545 (2001)
  14. International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use: Harmonised Triplicate Guideline on Validation of Analytical Procedures: Methodology, Recommended for Adoption at Step 4 of the ICH Process on November 1996 by the ICH Steering Committee, IFPMA, Switzerland (1996)